Go Pro

Crinetics Pharmaceuticals (CRNX) Institutional Ownership

Crinetics Pharmaceuticals logo
$83.58 0.00 (0.00%)
Closing price 07/10/2026 04:00 PM Eastern
Extended Trading
$84.08 +0.50 (+0.59%)
As of 05:34 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Crinetics Pharmaceuticals (NASDAQ:CRNX)

Current
Institutional Ownership
Percentage
98.51%
Number of
Institutional Buyers
(last 12 months)
146
Total
Institutional Inflows
(last 12 months)
$814.77M
Number of
Institutional Sellers
(last 12 months)
91
Total
Institutional Outflows
(last 12 months)
$312.17M
Get CRNX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Crinetics Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CRNX Institutional Buying and Selling by Quarter

Crinetics Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/10/2026 Handelsbanken Fonder AB36,000$1.35M0.0%+22.0%0.034%
6/3/2026Parallel Advisors LLC913$33K0.0%-25.5%0.001%
5/26/2026Glenmede Trust Co. NA29,245$1.06M0.0%+72.6%0.028%
5/22/2026Segall Bryant & Hamill LLC180,112$6.54M0.1%-4.9%0.171%
5/19/2026Bank of America Corp DE716,125$26.01M0.0%-10.6%0.679%
5/19/2026Janus Henderson Group PLC4,520,251$164.23M0.1%+1.8%4.287%
5/18/2026ADAR1 Capital Management LLC1,139,331$41.38M2.4%+268.3%1.081%
5/18/2026Amundi13,034$473K0.0%+131.8%0.012%
5/18/2026California State Teachers Retirement System105,563$3.83M0.0%+23.4%0.100%
5/18/2026Royal Bank of Canada49,778$1.81M0.0%+5.3%0.047%
5/16/2026The Manufacturers Life Insurance Company 147,680$5.36M0.0%-0.5%0.140%
5/16/2026Quantinno Capital Management LP33,734$1.23M0.0%+280.9%0.032%
5/16/2026First Light Asset Management LLC1,089,670$39.58M3.5%-8.8%1.033%
5/15/2026Rice Hall James & Associates LLC195,701$7.11M0.4%+13.9%0.186%
5/14/2026Gabelli Funds LLC6,000$218K0.0%N/A0.006%
5/14/2026Siren L.L.C.1,903,636$69.14M1.9%+26.3%1.805%
5/14/2026Sei Investments Co.73,961$2.69M0.0%+2.7%0.070%
5/13/2026First Trust Advisors LP51,365$1.87M0.0%+54.9%0.049%
5/7/2026Dimensional Fund Advisors LP852,258$30.94M0.0%+55.2%0.808%
5/7/2026Parallel Advisors LLC913$33K0.0%-25.5%0.001%
5/7/2026SEB Asset Management AB213,891$7.77M0.0%N/A0.203%
5/6/2026Jennison Associates LLC904,672$32.86M0.0%-29.4%0.858%
5/6/2026Assetmark Inc.16,292$592K0.0%-9.3%0.015%
5/5/2026Bank of New York Mellon Corp358,719$13.03M0.0%-11.4%0.340%
5/4/2026Principal Financial Group Inc.7,066$257K0.0%+32.3%0.007%
5/4/2026Teachers Retirement System of The State of Kentucky28,477$1.03M0.0%+4.0%0.027%
5/1/2026Fifth Third Bancorp3,470$126K0.0%N/A0.003%
4/25/2026Strs Ohio3,500$127K0.0%-34.0%0.003%
4/22/2026Pictet Asset Management Holding SA1,884,281$68.20M0.1%+20.8%1.800%
4/22/2026Braun Stacey Associates Inc.324,808$11.80M0.4%N/A0.310%
4/16/2026SG Americas Securities LLC9,571$348K0.0%-56.1%0.009%
3/17/2026Rockefeller Capital Management L.P.4,679$218K0.0%+12.5%0.004%
2/19/2026T. Rowe Price Investment Management Inc.59,121$2.75M0.0%-2.4%0.058%
2/19/2026Invesco Ltd.158,089$7.36M0.0%+76.8%0.155%
2/18/2026Mackenzie Financial Corp5,666$268K0.0%-4.6%0.006%
2/18/2026ADAR1 Capital Management LLC309,368$14.40M1.1%+24.6%0.303%
2/18/2026Virtus Investment Advisers LLC13,535$630K0.2%+282.7%0.013%
2/18/2026Wellington Management Group LLP8,037,889$374.16M0.1%-4.1%7.867%
2/18/2026Progeny 3 Inc.24,000$1.12M0.1%N/A0.023%
2/18/2026RTW Investments LP1,351,326$62.90M0.6%+54.9%1.323%
Trump's gold order: the announcement they won't put on the front page (Ad)

On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.tc pixel

Request the free guide in 30 seconds and get positioned now
2/18/2026Odyssean LLC15,848$738K0.5%N/A0.016%
2/18/2026Millennium Management LLC300,335$13.98M0.0%+38.9%0.294%
2/18/2026Man Group plc62,560$2.91M0.0%N/A0.061%
2/18/2026Janus Henderson Group PLC4,440,691$206.60M0.1%+15.1%4.346%
2/18/2026Cormorant Asset Management LP300,000$13.97M0.6%-25.0%0.294%
2/18/2026Balyasny Asset Management L.P.233,197$10.86M0.0%+1,560.4%0.228%
2/18/2026Baker BROS. Advisors LP1,648,869$76.76M0.4%+488.9%1.614%
2/17/2026ADAR1 Capital Management LLC309,368$14.40M1.0%+24.6%0.303%
2/17/2026Cetera Investment Advisers4,810$224K0.0%N/A0.005%
2/17/2026First Light Asset Management LLC1,194,263$55.59M4.3%+26.8%1.169%
2/17/2026Paradigm Biocapital Advisors LP2,210,774$102.91M2.6%-13.3%2.164%
2/17/2026Amundi5,622$262K0.0%N/A0.006%
2/17/2026Farallon Capital Management LLC6,933,098$322.74M1.5%+20.2%6.786%
2/17/2026Price T Rowe Associates Inc. MD5,224,387$243.20M0.0%-1.5%5.113%
2/17/2026T. Rowe Price Investment Management Inc.29,085$1.35M0.0%-52.0%0.028%
2/17/2026California State Teachers Retirement System85,568$3.98M0.0%+1.7%0.084%
2/17/2026Russell Investments Group Ltd.119,905$5.58M0.0%-19.5%0.117%
2/17/2026State of Wisconsin Investment Board55,561$2.59M0.0%-2.6%0.054%
2/17/2026Royal Bank of Canada47,295$2.20M0.0%-72.3%0.046%
2/17/2026Rice Hall James & Associates LLC171,830$8.00M0.4%-1.3%0.168%
2/16/2026Vanguard Personalized Indexing Management LLC8,524$397K0.0%+13.9%0.008%
2/16/2026MML Investors Services LLC5,394$251K0.0%N/A0.005%
2/16/2026Arax Advisory Partners1,498$70K0.0%+131.2%0.001%
2/16/2026Barclays PLC185,677$8.64M0.0%+1.3%0.182%
2/13/2026Prosight Management LP262,904$12.24M2.5%-20.0%0.257%
2/13/2026Kestra Advisory Services LLC2,922$136K0.0%N/A0.003%
2/13/2026The Manufacturers Life Insurance Company 148,489$7.00M0.0%+0.5%0.145%
2/13/2026CANADA LIFE ASSURANCE Co8,214$382K0.0%-63.6%0.008%
2/13/2026Segall Bryant & Hamill LLC189,477$8.82M0.1%+4.8%0.185%
2/13/2026Walleye Capital LLC4,931$230K0.0%N/A0.005%
2/13/2026Stifel Financial Corp21,200$987K0.0%-2.5%0.021%
2/13/2026Commerce Bank8,019$373K0.0%+5.9%0.008%
2/13/2026Smartleaf Asset Management LLC639$30K0.0%+107.5%0.001%
2/13/2026Schroder Investment Management Group187,433$8.88M0.0%+114.7%0.183%
2/13/2026Rafferty Asset Management LLC4,865$226K0.0%-21.3%0.005%
2/13/2026First Trust Advisors LP33,150$1.54M0.0%+378.3%0.032%
2/13/2026Headlands Technologies LLC23,217$1.08M0.1%+14.9%0.023%
2/13/2026Siren L.L.C.1,507,636$70.18M2.1%-10.7%1.476%
2/13/2026Charles Schwab Investment Management Inc.781,981$36.40M0.0%+0.4%0.765%
2/13/2026State Street Corp2,161,378$100.61M0.0%-2.1%2.115%
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC225,842$10.51M0.0%+3.7%0.221%
2/13/2026Wells Fargo & Company MN139,461$6.49M0.0%+41.3%0.136%
2/13/2026Castleark Management LLC62,790$2.92M0.1%N/A0.061%
2/12/2026Brooklyn Investment Group5,890$280K0.0%+6.3%0.006%
2/12/2026Orion Porfolio Solutions LLC30,495$1.42M0.0%+80.9%0.030%
2/12/2026MetLife Investment Management LLC49,818$2.32M0.0%-6.7%0.049%
2/12/2026Cibc World Markets Corp5,982$278K0.0%N/A0.006%
2/12/2026Dimensional Fund Advisors LP548,977$25.56M0.0%+45.3%0.537%
2/12/2026Decheng Capital LLC92,700$4.32M0.6%-35.2%0.091%
2/12/2026Ensign Peak Advisors Inc275,616$12.83M0.0%-6.6%0.270%
Your book attached (Ad)

Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel

Download the Safe Trade Options Formula book for free before access closes
2/12/2026Skandinaviska Enskilda Banken AB publ 213,891$9.96M0.0%+19.8%0.209%
2/12/2026New York State Common Retirement Fund146,123$6.80M0.0%-1.5%0.143%
2/12/2026Sector Gamma AS115,000$5.35M1.2%N/A0.113%
2/12/2026Alps Advisors Inc.77,765$3.62M0.0%+64.0%0.076%
2/12/2026Swiss National Bank176,500$8.22M0.0%+2.3%0.173%
2/12/2026Nuveen LLC522,466$24.32M0.0%-4.1%0.511%
2/11/2026Meeder Advisory Services Inc.4,646$216K0.0%N/A0.005%
2/11/2026Deutsche Bank AG235,018$10.94M0.0%+1.1%0.230%
2/11/2026GW&K Investment Management LLC1,476,325$68.72M0.6%+73.6%1.445%
2/11/2026Cerity Partners LLC18,974$883K0.0%N/A0.019%


CRNX Institutional Ownership - Frequently Asked Questions

During the previous two years, 258 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals. The most heavily invested institutionals were FMR LLC ($456.49M), Vanguard Group Inc. ($425.26M), Wellington Management Group LLP ($374.16M), Farallon Capital Management LLC ($322.74M), Price T Rowe Associates Inc. MD ($243.20M), Driehaus Capital Management LLC ($209.29M), and Janus Henderson Group PLC ($164.23M).Learn more on Crinetics Pharmaceuticals' institutional investors.

98.51% of Crinetics Pharmaceuticals' stock is owned by institutional investors. Learn more on CRNX's institutional investor holdings.

Of the 232 institutional investors that purchased Crinetics Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Farallon Capital Management LLC ($5.69M), Wellington Management Group LLP ($5.07M), FMR LLC ($4.83M), Vanguard Group Inc. ($3.02M), JPMorgan Chase & Co. ($1.92M), Vestal Point Capital LP ($1.71M), and Baker BROS. Advisors LP ($1.37M).

Institutional investors have bought a total of 19,506,661 shares in the last 24 months. This purchase volume represents approximately $814.77M in transactions.

Of the 91 institutional investors that sold Crinetics Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Jennison Associates LLC ($1.27M), Franklin Resources Inc. ($945.61K), Vestal Point Capital LP ($750K), SG Americas Securities LLC ($524.68K), Wellington Management Group LLP ($344.10K), Paradigm Biocapital Advisors LP ($340K), and Qube Research & Technologies Ltd ($230.15K).

Institutional investors have sold a total of 7,913,780 shares in the last 24 months. This volume of shares sold represents approximately $312.17M in transactions.



This page (NASDAQ:CRNX) was last updated on 7/13/2026 by MarketBeat.com Staff.
From Our Partners